168 related articles for article (PubMed ID: 10080601)
1. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
Smith MA; Rubinstein L; Anderson JR; Arthur D; Catalano PJ; Freidlin B; Heyn R; Khayat A; Krailo M; Land VJ; Miser J; Shuster J; Vena D
J Clin Oncol; 1999 Feb; 17(2):569-77. PubMed ID: 10080601
[TBL] [Abstract][Full Text] [Related]
2. Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Smith MA; Rubinstein L; Cazenave L; Ungerleider RS; Maurer HM; Heyn R; Khan FM; Gehan E
J Natl Cancer Inst; 1993 Apr; 85(7):554-8. PubMed ID: 8455202
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Smith MA; Rubinstein L; Ungerleider RS
Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
[TBL] [Abstract][Full Text] [Related]
4. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
[TBL] [Abstract][Full Text] [Related]
5. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
Le Deley MC; Leblanc T; Shamsaldin A; Raquin MA; Lacour B; Sommelet D; Chompret A; Cayuela JM; Bayle C; Bernheim A; de Vathaire F; Vassal G; Hill C;
J Clin Oncol; 2003 Mar; 21(6):1074-81. PubMed ID: 12637473
[TBL] [Abstract][Full Text] [Related]
6. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Kushner BH; Heller G; Cheung NK; Wollner N; Kramer K; Bajorin D; Polyak T; Meyers PA
J Clin Oncol; 1998 Sep; 16(9):3016-20. PubMed ID: 9738570
[TBL] [Abstract][Full Text] [Related]
7. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
RamaChandran S; Ariffin H
Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis.
Henter JI; Elinder G; Lübeck PO; Ost A
Pediatr Hematol Oncol; 1993; 10(2):163-8. PubMed ID: 8318372
[TBL] [Abstract][Full Text] [Related]
10. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
Pui CH; Relling MV; Behm FG; Hancock ML; Boyett JM; Raimondi SC; Krance RA; Mahmoud HH; Ribeiro RC; Sandlund JT
Leukemia; 1995 Oct; 9(10):1680-4. PubMed ID: 7564509
[TBL] [Abstract][Full Text] [Related]
11. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults.
Le Deley MC; Vassal G; Taïbi A; Shamsaldin A; Leblanc T; Hartmann O
Pediatr Blood Cancer; 2005 Jul; 45(1):25-31. PubMed ID: 15795880
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
Yagita M; Ieki Y; Onishi R; Huang CL; Adachi M; Horiike S; Konaka Y; Taki T; Miyake M
Int J Oncol; 1998 Jul; 13(1):91-6. PubMed ID: 9625808
[TBL] [Abstract][Full Text] [Related]
13. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
[TBL] [Abstract][Full Text] [Related]
15. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
Weintraub M; Revel-Vilk S; Charit M; Aker M; Pe'er J
J Pediatr Hematol Oncol; 2007 Sep; 29(9):646-8. PubMed ID: 17805043
[TBL] [Abstract][Full Text] [Related]
16. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
[TBL] [Abstract][Full Text] [Related]
17. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
18. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
19. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
20. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
